Abstract
Currently, the molecular characteristics of the occurrence and course of neurodegenerative diseases, which are among the most serious and still incurable illnesses, remain to be fully elucidated. Therefore, the search for novel medicines for the removal, relief, or postponement of symptoms in these pathologies remains relevant. In view of the complexity of undertaking this research in human, the identification of genes associated with developing neurodegenerative changes and the study of their functions in different (neuronal and glial) tissues and at different stages of ontogenesis are carried out in model systems. Drosophila melanogaster is one of the best and available objects for the identification of molecular genetic mechanisms underlying the development of neurodegeneration as well as for the initial tests of novel compounds with neuroprotective properties. This article discusses the methods of genetic analysis in Drosophila, the use of D. melanogaster as a model of human neurodegenerative disorders, and a possibility of using its model as test systems for the study of potential neuroprotectors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.